Lipocine Inc reports results for the quarter ended in March - Earnings Summary

Lipocine

11/05/2023 12:20

* Lipocine Inc  LPCN.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 2
cents per share.
    * Revenue was $54.99 million​; analysts expected $777.00
thousand. 
    * Lipocine Inc's reported EPS for the quarter was a loss
of 4
cents​.
    * The mean earnings estimate of analysts had risen by
about 16.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lipocine Inc shares had fallen by 16.5% this quarter and
lost 33.2% so far this year.
    * The company reported a quarterly loss of $3.87 million.
    * Wall Street's median 12-month price target for Lipocine
Inc is
$4.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 11:20 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.02          -0.04          Missed
 Dec. 31 2022      -0.03          -0.03          Met
 Sep. 30 2022      -0.03          -0.03          Met
 Jun. 30 2022      -0.04          -0.03          Beat